Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...
Medpage Today on MSN8h
Combination Slows Metastatic CRC Progression Better Than Single ImmunotherapyMedian duration of therapy was 20.5 months for the combination and 16.4 months with single-agent nivolumab. Median number of ...
The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...
Hosted on MSN20h
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic CancerThe findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...
The AstraZeneca PLC ADR AZN rallied 1.48% to $70.08 Monday, on what proved to be an all-around mixed trading session for the ...
A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...
5don MSN
President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.
AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo.
The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...
Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the ...
The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...
Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback